CadexGenomics: Taking the Fight to Stage 4 Cancer (215)

Episode 15 May 21, 2022 00:28:00
CadexGenomics: Taking the Fight to Stage 4 Cancer (215)
Innovation4Alpha
CadexGenomics: Taking the Fight to Stage 4 Cancer (215)

May 21 2022 | 00:28:00

/

Show Notes

The Cadex Genomics mission and passion is to improve the lives of cancer patients. They have developed a novel, blood-based assays for patients with cancer. Over the past several years they have been working diligently to bring their first product to patients and the physicians who serve these patients. They are currently developing a new product called Alibrex, which is a blood-based assay that allows physicians to detect, in real-time, if the disease of their stage IV cancer patients is progressing. 

Alibrex is currently at the clinical stage and will be available commercially in 2023. The team members have successful track records commercializing molecular diagnostics for oncology at companies including Genomic Health (now part of Exact Sciences), Castle Biosciences and Veracyte. Science and clinical team members are affiliated with the University of New Orleans, Tulane University and the University of California at San Francisco (UCSF). Independent board directors include the Chief Legal and Regulatory Officer for 23 and Me. 

Other Episodes

Episode 7

March 01, 2022 00:31:53
Episode Cover

Saralyn Mark, MD - Human centered design on Earth and in Space (207)

Saralyn Mark, MD, a world renowned leader in women’s health, is an endocrinologist, geriatrician and women’s health specialist. She was the first Senior Medical...

Listen

Episode 2

January 11, 2022 00:16:45
Episode Cover

David Finkel Founder/CEO of Maui Mastermind - (Part 2) (202)

Listen

Episode

June 13, 2021 00:49:54
Episode Cover

Venture Investing for Physicians (002)

In this episode, host Tobin Arthur is joined by colleague Michael Schmanske in a discussion with DJ Verret, MD, a plastic surgeon and seasoned...

Listen